Alterity Therapeutics (ASX:ATH) Dividends Paid: A$0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:ATH Alterity Therapeutics Ltd ASX:ATH
25 GF Score
Price A$0.56
View Full Analysis

What is Alterity Therapeutics Dividends Paid?

Alterity Therapeutics ASX:ATH -5.08% 25 Dividends Paid is A$0.00 Mil as of Mar. 2026. GuruFocus rates ASX:ATH with a GF Score™ of 25/100.

Alterity Therapeutics's Dividends Paid for the three months ended in Mar. 2026 was A$0.00 Mil.

Alterity Therapeutics's Dividends Paid for the trailing twelve months (TTM) ended in Mar. 2026 was A$0.00 Mil.

Alterity Therapeutics Dividends Paid Related Terms

Alterity Therapeutics Dividends Paid Historical Data

* Premium members only.

The historical data trend for Alterity Therapeutics's Dividends Paid can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alterity Therapeutics Dividends Paid Chart

Alterity Therapeutics Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Dividends Paid
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Alterity Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividends Paid Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:ATH
25GF Score
Alterity Therapeutics Ltd ASX:ATH
Dividends Paid is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alterity Therapeutics Dividends Paid Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Dividends Paid represents dividend paid to the investors in the direct cash flow method.

Dividends Paid for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividends Paid →
What does a Dividends Paid of A$0.00 Mil mean?
Alterity Therapeutics (ASX:ATH) has a Dividends Paid of A$0.00 Mil as of Mar. 2026. Dividends Paid represents dividend paid to the investors in direct cash flow method. View historical data for Alterity Therapeutics and its competitors.
Is Alterity Therapeutics' Dividends Paid too high?
Alterity Therapeutics' current Dividends Paid is A$0.00 Mil. Overall, Alterity Therapeutics has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Alterity Therapeutics' Dividends Paid compare to VRTX and REGN?
Alterity Therapeutics' Dividends Paid of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends Paid for a Biotechnology company?
A good Dividends Paid depends on the Biotechnology industry context. However, Dividends Paid should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends Paid mean?
A high Dividends Paid can signal that a stock is expensive relative to its fundamentals. Dividends Paid represents dividend paid to the investors in direct cash flow method. View historical data for Alterity Therapeutics and its competitors. Alterity Therapeutics's current Dividends Paid is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alterity Therapeutics stock overvalued right now?
Alterity Therapeutics (ASX:ATH) has a current Dividends Paid of A$0.00 Mil. The current Dividends Paid is A$0.00 Mil. Alterity Therapeutics' overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends Paid calculated?
Dividends Paid is calculated from a company's financial statements. For Alterity Therapeutics (ASX:ATH), the current Dividends Paid is A$0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alterity Therapeutics Business Description

Other Exchanges ATHE:USAPBN:Germany
Address 350 Collins Street, Suite 4, Level 14, Melbourne, VIC, AUS, 3000
Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment, research and development into Parkinsonian and other neurodegenerative disorders.
25GF Score

Get the complete analysis for ASX:ATH

Dividends Paid is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.56
Price